Complex molecular regulation of tyrosine hydroxylase
The DOI matches its Crossref record; 292 of the 294 references it cites were found in a registry or an index.
Abstract
Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis, is strictly controlled by several interrelated regulatory mechanisms. Enzyme synthesis is controlled by epigenetic factors, transcription factors, and mRNA levels. Enzyme activity is regulated by end-product feedback inhibition. Phosphorylation of the enzyme is catalyzed by several protein kinases and dephosphorylation is mediated by two protein phosphatases that establish a sensitive process for regulating enzyme activity on a minute-to-minute basis. Interactions between tyrosine hydroxylase and other proteins introduce additional layers to the already tightly controlled production of catecholamines. Tyrosine hydroxylase degradation by the ubiquitin-proteasome coupled pathway represents yet another mechanism of regulation. Here, we revisit the myriad mechanisms that regulate tyrosine hydroxylase expression and activity and highlight their physiological importance in the control of catecholamine biosynthesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Coincident detection of onecut-3 and enzymatically-active TH phosphorylated at residue Ser40 26 on a Th- GFP background revealed that these dopamine neurons populate the periventricular nucleus of the hypothalamus (Fig. 5d), with their dendritic trees being primarily oriented vertically”
From Molecular interrogation of hypothalamic organization reveals distinct dopamine neuronal subtypes (2017) · cites this paper as [26]
In the citing paper
“This mark showed a distinct difference in the rising slope of cumulative distribution of function (CDF; p = 0.0167), suggesting different levels of active TH enzyme at day and night periods”
From Molecular interrogation of hypothalamic organization reveals distinct dopamine neuronal subtypes (2017) · cites this paper as [26]
Citations
Cites
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Purification and Characterization
(2006) · Biomacromolecules · doi:10.1002/0470080124.ch3 · Cited by 2,309
Nagatsu, T., Levitt, M., & Udenfriend, S. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93832-9 · Cited by 2,058
ERK1/2 MAP kinases: Structure, function, and regulation
Roskoski, R. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.04.005 · Cited by 1,650
Self-citationThe origins of protein phosphorylation
Cohen, P. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e127 · Cited by 1,139
Dopamine Neuron Agenesis in Nurr1-Deficient Mice
Zetterström, R. H., Solomin, L., Jansson, L., Hoffer, B. J., Olson, L., & Perlmann, T. (1997) · Science · doi:10.1126/science.276.5310.248 · Cited by 1,092
Tyrosine hydroxylase and regulation of dopamine synthesis
Daubner, S. C., Le, T., & Wang, S. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.12.017 · Cited by 1,092
Levitt, M., Spector, S., Sjoerdsma, A., & Udenfriend, S. (1965) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27006-9 · Cited by 1,025
Intricate Regulation of Tyrosine Hydroxylase Activity and Gene Expression
Kumer, S. C., & Vrana, K. E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67020443.x · Cited by 679
Self-citationA Role for α-Synuclein in the Regulation of Dopamine Biosynthesis
Perez, R. G., Waymire, J. C., Lin, E., Liu, J. J., Guo, F., & Zigmond, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03090.2002 · Cited by 598
Research works printed but not linked: 1
- Xu ZQ, Lew JY, Harada K, Aman K, Goldstein M, Deutch A, Haycock JW, Hokfelt T (1998b) Immunohistochemical studies on phosphorylation of tyrosine hydroxylase in central catecholamine neurons using site- and phosphorylation state-specific antibodies. Neuroscience 82(3):727–738
Cited by
Current Challenges and Opportunities in Treating Glioblastoma
Shergalis, A., Bankhead, A., Luesakul, U., Muangsin, N., & Neamati, N. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014944 · Cited by 849
Molecular interrogation of hypothalamic organization reveals distinct dopamine neuronal subtypes
Romanov, R. A., Zeisel, A., Bakker, J., Girach, F., Hellysaz, A., Tomer, R., Alpár, A., Mulder, J., Clotman, F., Keimpema, E., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4462 · Cited by 502
PI3K/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression
Guo, N., Wang, X., Xu, M., Bai, J., Yu, H., & Zhang, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107300 · Cited by 218
Nagatsu, T., & Nagatsu, I. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1596-4 · Cited by 119
“TH activity is regulated also through different mechanisms at the levels of transcription of the gene and posttranscriptional modification of the protein in acute and chronic periods (Messer et al. 1999; Tekin et al. 2014),”
BackgroundBueno-Carrasco, M. T., Cuéllar, J., Flydal, M. I., Santiago, C. A., Kråkenes, T.-A., Kleppe, R., López‐Blanco, J. R., Marcilla, M., Teigen, K., Alvira, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27657-y · Cited by 118
Dopamine beta‐hydroxylase and its genetic variants in human health and disease
Gonzalez‐Lopez, E., & Vrana, K. E. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14893 · Cited by 102
“(2020) 152, 157--181 157 1966; Oka et al. 1967; Jonsson and Sachs 1976; Tekin et al. 2014).”
Self-citationTyrosine and tryptophan hydroxylases as therapeutic targets in human disease
Waløen, K., Kleppe, R., Martínez, A., & Haavik, J. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1272581 · Cited by 96
“TH is mainly expressed in the noradrenergic and dopaminergic neurons of the brain, chromaffin cells of the adrenal medulla, and sympathetic neurons [8,16].”
BackgroundPresynaptic regulation of dopamine release: Role of the DAT and VMAT2 transporters
Mulvihill, K. G. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.11.004 · Cited by 90
Intact innervation is essential for diet-induced recruitment of brown adipose tissue
Fischer, A. W., Schlein, C., Cannon, B., Heeren, J., & Nedergaard, J. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00443.2018 · Cited by 81
Fitzpatrick, P. F. (2023) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2023.109518 · Cited by 74
Willing, J., Cortes, L. R., Brodsky, J. M., Kim, T., & Juraska, J. M. (2017) · Developmental Psychobiology · doi:10.1002/dev.21525 · Cited by 68
The neuromodulatory effects of flavonoids and gut Microbiota through the gut-brain axis
Wang, H., Zhao, T., Liu, Z., Danzengquzhen, Cisangzhuoma, Ma, J., Li, X., Huang, X., & Li, B. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1197646 · Cited by 78
“Tyrosine hydroxylase (TH) is a key enzyme that catalyzes the conversion of tyrosine into norepinephrine and dopamine (Tekin et al., 2014).”
BackgroundMitok, K. A., Freiberger, E. C., Schueler, K. L., Rabaglia, M. E., Stapleton, D. S., Kwiecien, N. W., Malec, P. A., Hebert, A. S., Broman, A. T., Kennedy, R. T., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001102 · Cited by 64
ADHD symptoms in neurometabolic diseases: Underlying mechanisms and clinical implications
Homaei, S. C., Halleland, H. B., Kleppe, R., Betari, N., Reif, A., & Haavik, J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.012 · Cited by 64
“different regulatory mechanisms have been reported (Dunkley and Dickson, 2019; Tekin et al., 2014).”
Sabban, E. L., Lauková, M., Alaluf, L. G., Olsson, E., & Serova, L. I. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13347 · Cited by 63
“The discrepancy between higher levels of TH protein and no changes in mRNA could also be a consequence of differences in stability of TH mRNA and protein as a result of post-transcriptional and post-translational modifications [rev. in (Tank et al. 2008; Tekin et al. 2014)].”
Inflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis
Byrne, C. J., Khurana, S., Kumar, A., & Tai, T. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00343 · Cited by 58
Johnson, M., Salvatore, M. F., Maiolo, S., & Bobrovskaya, L. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.01.002 · Cited by 54
Hypothalamic CNTF volume transmission shapes cortical noradrenergic excitability upon acute stress
Alpár, A., Zahola, P., Hanics, J., Hevesi, Z., Korchynska, S., Benevento, M., Pifl, C., Zachár, G., Perugini, J., Severi, I., et al. (2018) · The EMBO Journal · doi:10.15252/embj.2018100087 · Cited by 50
“TH is the rate-limiting enzyme of NE production with its activity regulated by phosphorylation at Ser 31 (but not Ser 40 ; Zigmond et al , 1989; Dickson & Briggs, 2013; Tekin et al , 2014).”
Chitre, N. M., Wood, B. J., Ray, A., Moniri, N. H., & Murnane, K. S. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107976 · Cited by 52
“Interestingly, the downstream PKA activator FSK recapitulated the dopamine restorative effects of DHA to some extent, validating that direct stimulation of TH at Ser40 by PKA increases enzyme activity leading to dopamine restorative effects, as established previously (Daubner et al., 2011; Dunkley et al., 2004; Sura e…”
BackgroundYang, Y., Liu, M., Xiao, C., Li, W.-H., Zhang, S., Wang, Y., & Du, G. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577049 · Cited by 40
Autonomic regulation of T-lymphocytes: Implications in cardiovascular disease
Elkhatib, S. K., & Case, A. J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104293 · Cited by 42
Lin, L., Yu, L., Xiang, H.-C., Hu, X., Yuan, X., Zhu, H., Li, H., Zhang, H., Hou, T., Cao, J., et al. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00239 · Cited by 35
Bae, G. E., Kim, H. S., Won, K. Y., Kim, G. Y., Sung, J., & Lim, S.-J. (2018) · Anticancer Research · doi:10.21873/anticanres.13102 · Cited by 33
Lasley, S. M., Fornal, C. A., Mandal, S., Strupp, B. J., Beaudin, S. A., & Smith, D. R. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz208 · Cited by 37
“TH, the ratelimiting synthetic enzyme for catecholamines, is subject to epigenetic, transcriptional, and post-transcriptional regulation (eg, Banerjee et al., 2013; Tekin et al., 2014), but the effects of developmental and/or long term exposure to Mn in vivo on this enzyme have received little attention.”
BackgroundXiao, G., Zhao, M., Liu, Z., Du, F., & Zhou, B. (2021) · BMC Biology · doi:10.1186/s12915-021-01168-0 · Cited by 33
Maeda, H. A., Chiyonobu, T., Yoshida, M., Yamashita, S., Zuiki, M., Kidowaki, S., Isoda, K., Yamakawa, K., Morimoto, M., Nakahata, T., et al. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.5 · Cited by 32
ASL Metabolically Regulates Tyrosine Hydroxylase in the Nucleus Locus Coeruleus
Lerner, S., Anderzhanova, E. A., Verbitsky, S., Eilam, R., Kuperman, Y., Tsoory, M., Kuznetsov, Y., Brandis, A. S., Mehlman, T., Mazkereth, R., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.043 · Cited by 31
“CREB is one of the main transcription factors that regulate TH expression and its downstream effects (Harraz and Snyder, 2015; Tekin et al., 2014; Xu et al., 2013).”
BackgroundHuang, L., Deng, M., Zhang, S., Lu, S. Y., Gui, X., & Fang, Y. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.125 · Cited by 31
Braun, D. J., Kalinin, S., & Feinstein, D. L. (2017) · ASN NEURO · doi:10.1177/1759091417696161 · Cited by 30
“…to insult due to a combination of high bioenergetic need (SanchezPadilla et al., 2014), high-oxidative stress as a byproduct of NA synthesis (Tekin et al., 2014), large exposure to blood circulation (Pamphlett, 2014), and sensitivity to both central and peripheral inflammation (Kaneko et…”
BackgroundMiękus, N., Olędzka, I., Plenis, A., Kowalski, P., Bień, E., Miękus, A., Krawczyk, M. A., Adamkiewicz-Drożyńska, E., & Bączek, T. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.10.007 · Cited by 25
Szigetvari, P. D., Muruganandam, G., Kallio, J. P., Hallin, E. I., Fossbakk, A., Loris, R., Kursula, I., Møller, L. B., Knappskog, P. M., Kursula, P., et al. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14624 · Cited by 29
“A 42-residue long domain with a coiled-coil motif present at the C-terminus of the polypeptide facilitates oligomerization (Vrana et al. 1994; Goodwill et al. 1997; Tekin et al. 2014).”
BackgroundShehadeh, J., Double, K. L., Murphy, K. E., Bobrovskaya, L., Reyes, S., Dunkley, P. R., Halliday, G. M., & Dickson, P. W. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104524 · Cited by 26
Guo, D., Zhang, S., Sun, H., Xu, X., Hao, Z., Mu, C., Xu, X., Wang, G., & Ren, H. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000618 · Cited by 29
Wang, Y., Chen, X., Wang, Y. Y., Li, S., Cai, H., & Le, W. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04319-x · Cited by 25
Freyberg, Z., & Gittes, G. K. (2022) · Diabetes · doi:10.2337/db22-0522 · Cited by 24
Szigetvari, P. D., Patil, S. S., Birkeland, E., Kleppe, R., & Haavik, J. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105629 · Cited by 23
“While in vitro experiments consistently show that substrate inhibition is an inherent property of TH (Barone et al., 2020; Quinsey et al., 1998; Szigetvari et al., 2019; Tekin et al., 2014), conclusions drawn from studies using cell cultures and live animals have been inconsistent.”
Parlak, H., Özkan, A., Dilmaç, S., Tanrιöver, G., Özsoy, Ö., & Ağar, A. (2015) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2018.0005 · Cited by 24
Catecholamines: Knowledge and understanding in the 1960s, now, and in the future
Stanford, S. C., & Heal, D. J. (2019) · Brain and Neuroscience Advances · doi:10.1177/2398212818810682 · Cited by 24
“It is now known that TH also undergoes transcriptional, translational, and epigenetic regulation, which culminates in long-term adjustments in the production and activity of this enzyme that are essential for maintenance of homeostasis (see Tekin et al., 2014).”
BackgroundDopamine synthesis and transport: current and novel therapeutics for parkinsonisms
Tai, M. D. S., Gamiz-Arco, G., & Martínez, A. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231061 · Cited by 22
van Hooijdonk, C. F. M., van der Pluijm, M., Bosch, I., van Amelsvoort, T., Booij, J., de Haan, L., Selten, J., & van de Giessen, E. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.12.008 · Cited by 23
Bmal1-knockout mice exhibit reduced cocaine-seeking behaviour and cognitive impairments
Castro‐Zavala, A., Alegre-Zurano, L., Cantacorps, L., Gallego‐Landin, I., Welz, P.-S., Benitah, S. A., & Valverde, O. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113333 · Cited by 22
Ichinose, T., Murasawa, H., Ishijima, T., Okada, S., Abe, K., Matsumoto, S., Matsui, T., & Furuya, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232233 · Cited by 22
“Because the rate-limiting enzyme in the metabolism of catecholamine from Tyr is Th [41], Tyr-Trp intake presumably promoted NE synthesis and metabolism by supplying the catecholamine precursor Tyr and the Th coenzyme BH4 (Fig 5).”
BackgroundSenthilkumaran, M., Johnson, M., & Bobrovskaya, L. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1875-3 · Cited by 19
“nism has been shown to play a role in the regulation of TH gene expression but not in TH phosphorylation [58].”
BackgroundFaltraco, F., Palm, D., Uzoni, A., Borchert, L., Simon, F. A. J., Tucha, O. M., & Thome, J. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02374-4 · Cited by 24
“Dopamine is produced by dopaminergic neurons in the brain from aminoacid tyrosine, which is converted into dihydroxyphenylalanine (DOPA) by a rate-limiting enzyme, tyrosine hydroxylase (TH) (Tekin et al. 2014).”
BackgroundLocus coeruleus catecholamines link neuroticism and vulnerability to tau pathology in aging
Parent, J. H., Ciampa, C. J., Harrison, T. M., Adams, J. N., Zhuang, K., Betts, M. J., Maaß, A., Winer, J. R., Jagust, W. J., & Berry, A. S. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119658 · Cited by 22
“Catecholamine systems are highly regulated, and synthesis rates may be reduced in response to greater tonic activity of LC or upregulation of beta adrenergic receptors, as there are known mechanisms of feedback inhibition to suppress catecholamine synthesis (Tekin et al., 2014).”
BackgroundDobolyi, Á., & Lékó, A. H. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.12.002 · Cited by 18
Xu, X., Wang, R., Hao, Z., Wang, G., Mu, C., Ding, J., Sun, W., & Ren, H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29000 · Cited by 16
Poetini, M. R., Musachio, E. A. S., Araújo, S. M., Bortolotto, V. C., Meichtry, L. B., Silva, N. C., Janner, D. E., Novo, D. L. R., Mesko, M. F., Roehrs, R., et al. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.02.004 · Cited by 19
Brodnik, Z. D., Double, M., España, R. A., & Jaskiw, G. E. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.030 · Cited by 18
“…amino acid distribution can be challenged, ii) high TH activity may affect L-TYR levels (Bongiovanni et al., 2006) and that iii) individual in vitro enzyme characterization studies typically examine o ly a few of the many factors that may be involved in TH regulation in vivo (Tekin et al., 2014).”
BackgroundNouraei, N., Zarger, L., Weilnau, J. N., Han, J., Mason, D. M., & Leak, R. K. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.02.010 · Cited by 16
“…and Oertel, 1994), FluoroGold was employed in the present study to avoid the potential confound of stress-induced changes in TH expression in the absence of parallel changes in cell numbers (Baruchin et al., 1990; Chang et al., 2000; Kumer and Vrana, 1996; Tank et al., 2008; Tekin et al., 2014).”
MethodZheng, C., Chen, G., Tan, Y., Zeng, W., Peng, Q., Wang, J., Cheng, C., Yang, X., Nie, S., Xu, Y., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00417 · Cited by 14
“The activated form of ERK1/2, p-ERK1/2, is able to regulate the transcription and phosphorylation of TH (Tekin et al., 2014), and also could mediate the functions of TRH through TRH type 1 receptor (TRH-R1) (Choi et al.”
BackgroundFiory, F., Mirra, P., Nigro, C., Pignalosa, F. C., Zatterale, F., Ulianich, L., Prevete, N., Formisano, P., Bèguinot, F., & Miele, C. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27898 · Cited by 16
“TH expression is tightly regulated at both the transcriptional and posttranscriptional levels (Dunkley, Bobrovskaya, Graham, von Nagy‐ Felsobuki, & Dickson, 2004; Tekin et al., 2014).”
BackgroundInfluentialWeinberg, R. P., Koledova, V. V., Subramaniam, A., Schneider, K., Artamonova, A., Sambanthamurthi, R., Hayes, K. C., Sinskey, A. J., & Rha, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-54461-y · Cited by 16
Wąsik, A., Romańska, I., Zelek-Molik, A., & Antkiewicz‐Michaluk, L. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9824-8 · Cited by 13
Study of GCH1 and TH genes in Chinese patients with Parkinson's disease
Yan, Y., Zhang, B., Shen, T., Si, X., Guo, Z., Tian, J., Xu, C., & Zhang, B. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.02.004 · Cited by 12
Lékó, A. H., Cservenák, M., Szabó, É. R., Hanics, J., Alpár, A., & Dobolyi, Á. (2017) · Scientific Reports · doi:10.1038/s41598-017-03645-5 · Cited by 14
Caridade-Silva, R., Araújo, B., Martins‐Macedo, J., & Teixeira, F. G. (2023) · Antioxidants · doi:10.3390/antiox12061257 · Cited by 16
“As TH is subject to stress-induced changes [98], downregulation could result from decreased sensitivity to the binding method.”
BackgroundRegulation of tyrosine hydroxylase: relevance to Parkinson's disease
Alam, G., & Richardson, J. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815950-7.00004-7 · Cited by 13
Vavřínová, A., Behuliak, M., Vaněčková, I., & Zicha, J. (2021) · Physiological Research · doi:10.33549/physiolres.934687 · Cited by 13
“Tyrosine hydroxylation is a rate-limiting step of catecholamine synthesis and it is a subject of complex regulation, including direct inhibition of the enzyme by catecholamines, post-translational modifications and changes in the transcription of Th gene (for review see Tekin et al. 2014).”
Backgroundde Siqueira, E. A., Magalhães, E. P., de Assis, A. L. C., Sampaio, T. L., Lima, D. B., Marinho, M. M., Martins, A. M. C., de Andrade, G. M., & Viana, G. S. D. B. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03735-5 · Cited by 10
Senthilkumaran, M., & Bobrovskaya, L. (2017) · Autonomic Neuroscience · doi:10.1016/j.autneu.2017.12.004 · Cited by 9
Nora, G. J., Harun, R., Fine, D. F., Hutchison, D. F., Grobart, A. C., Stezoski, J. P., Munoz, M. J., Kochanek, P. M., Leak, R. K., Drábek, T., et al. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14058 · Cited by 11
Blood and Brain Biochemistry and Behaviour in NTBC and Dietary Treated Tyrosinemia Type 1 Mice
van Ginkel, W. G., van Vliet, D., van der Goot, E., van Faassen, M. H. J. R., Vogel, A., Heiner-Fokkema, M. R., van der Zee, E. A., & van Spronsen, F. J. (2019) · Nutrients · doi:10.3390/nu11102486 · Cited by 9
Jiang, K., Yu, H., Kong, L., Liu, S., Du, S., & Li, Q. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.741500 · Cited by 8
Hyperphenylalaninemia and serotonin deficiency in Dnajc12-deficient mice
Cao, Y., Popp, O., Milani, N., Qadri, F., Kühn, R., Mertins, P., Bäder, M., & Alenina, N. V. (2024) · Communications Biology · doi:10.1038/s42003-024-07360-6 · Cited by 10
Expression of the Tyrosine Hydroxylase Gene from Rat Leads to Oxidative Stress in Potato Plants
Kostyń, K., Boba, A., Kostyn, A., Kozak, B., Starzycki, M., Kulma, A., & Szopa, J. (2020) · Antioxidants · doi:10.3390/antiox9080717 · Cited by 8
“It must be noted that TH shows some substrate promiscuity, with specificity constant (V max/K m) for phenylalanine and tryptophan being 10-fold lower and 30-fold lower than that for tyrosine, respectively [36].”
BackgroundTyrosine hydroxylase phosphorylation is under the control of serine 40
Stoop, J., Douma, E. H., van der Vlag, M., Smidt, M. P., & van der Heide, L. P. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15963 · Cited by 9
“Subsequent to Ser40 phosphorylation, the ferrous iron therefore further facilitates enzymatic activity (Chow et al., 2009; Fitzpatrick, 1999; Tekin et al., 2014).”
BackgroundTyrosine hydroxylase activity is regulated through the modification of the 176th cysteine residue
Inukai, S., Hara, S., & Ichinose, H. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.12.024 · Cited by 7
Role of epigenetic regulation on catecholamine synthesis in pheochromocytoma and paraganglioma
Kaplinsky, A., Halperin, R., Shlomai, G., & Tirosh, A. (2024) · Cancer · doi:10.1002/cncr.35426 · Cited by 8
Yaglova, N. V., Timokhina, E. P., Yaglov, V. V., Obernikhin, S. S., Nazimova, S. V., & Tsomartova, D. A. (2020) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-020-04895-6 · Cited by 9
Does sympathetic dysfunction occur before denervation in pure autonomic failure?
Guo, L., Esler, M., Sari, C. I., Phillips, S. E., Lambert, É., Straznicky, N. E., Lambert, G. W., & Corcoran, S. J. (2018) · Clinical Science · doi:10.1042/cs20170240 · Cited by 7
González-Sepúlveda, M., Omar, M. Y., Hamdon, S., Ma, G., Rosell-Vilar, S., Raivio, N., Abass, D., Martínez-Rivas, A., Vila, M., Giraldo, J., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109058 · Cited by 7
Deal, S. L., Bei, D., Gibson, S., Delgado-Seo, H., Fujita, Y., Wilwayco, K., Seto, E., Sehgal, A., & Yamamoto, S. (2025) · iScience · doi:10.1016/j.isci.2025.114388 · Cited by 9
Dmitrieva, S. А., Vologin, S., Tsentsevitsky, A. N., Arkhipov, A. Y., Khuzakhmetova, V. F., Sibgatullina, G., & Bukharaeva, E. A. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923030069 · Cited by 7
“After the final washing NMPs were placed on glass slides and embedded in a Surgipath SubX mounting medium (Leica, Germany).”
MethodGomez‐Flores, R., Gutierrez-Leal, I., Caballero-Hernández, D. E., Orozco-Flores, A. A., Tamez‐Guerra, P., Támez-Guerra, R., & Rodrı́guez-Padilla, C. (2021) · BMC Research Notes · doi:10.1186/s13104-021-05507-w · Cited by 6
Florio, A. D., Alexander, D. C., Schmidt, P. J., & Rubinow, D. R. (2018) · Depression and Anxiety · doi:10.1002/da.22827 · Cited by 6
Guil, M. J., Schöller, M. I., Cassinotti, L. R., Biancardi, V. C., Pitra, S., Bianciotti, L. G., Stern, J. E., & Vatta, M. S. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.08.003 · Cited by 6
“Given that the ubiquitin-proteasome system degrades mainly TH phosphorylated at Ser 19 and Ser40 sites, the implication of this finding is presently unknown [56,60].”
BackgroundA novel tyrosine hydroxylase variant in a group of Chinese patients with dopa-responsive dystonia
Yan, Y., Zhang, B., Mao, Y., Guo, Z., Tian, J., Zhao, G., Pu, J., Luo, W. F., Ouyang, Z., & Zhang, B. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1236381 · Cited by 5
“phosphorylated by protein kinases [28,29]; (2) the catalytic domain, which binds the substrates oxygen and tyrosine and the cofactor tetrahydrobiopterin and (3) the tetramerization domain [30].”
BackgroundNisimura, L. M., Bousquet, P., Muccillo, F., Tibiriçá, E. V., & Garzoni, L. R. (2020) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20209615 · Cited by 5
“Tyrosine hydroxylase (TH) is a rate-limiting enzyme in catecholamine synthesis and a key component of the central and peripheral SNS (7).”
BackgroundInfluentialYi, O., Hu, S., Chang, M., Xu, J., Tian, G., Kong, X., Liu, J., Zhang, D. H., Zhang, F., Yang, H., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155697 · Cited by 4
Differential effects of mineralocorticoid and angiotensin II on incentive and mesolimbic activity
Grafe, L. A., & Flanagan‐Cato, L. M. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.12.002 · Cited by 4
“Serine 31, the residue attended to in the present study, is 224 phosphorylated by depolarization and extracellular receptor-activated kinases 1 and 2 225 (Tekin et al., 2014).”
Tekin, I., Carkaci‐Salli, N., Lewis, M. M., Mailman, R. B., Huang, X., & Vrana, K. E. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.12.015 · Cited by 4
“The pathological hallmark of PD is the loss of dopamine neurons in the substantia nigra pars compacta, including a reduction in tyrosine hydroxylase (TH), the rate limiting enzyme in catecholamine synthesis[2,3].”
BackgroundSelf-citationHistamine and Its Receptors as a Module of the Biogenic Amine Diseasome
Rodríguez-López, R., Morales, M., & Sánchez‐Jiménez, F. (2016) · The Receptors · doi:10.1007/978-3-319-40308-3_7 · Cited by 5
Won, S.-Y., You, S.-T., Choi, S.-W., McLean, C., Shin, E., & Kim, E. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.2250 · Cited by 4
“Cells 2021; 44(7): 493-499 patients with PD. Tyrosine hydroxylase (TH) is the rate-limiting enzyme of DA synthesis (Tekin et al., 2014; Zhu et al., 2012); thus, regulation of TH protein levels and activity represent a central means for controlling DA synthesis.”
BackgroundVariations in adrenal gland medulla and dopamine effects induced by the lack of Irs2
Catalano-Iniesta, L. A., Osma, M. D. C. I., Sánchez‐Robledo, V., Carretero‐Hernández, M., Blanco, E. J., Carretero, J., & García‐Barrado, M. J. (2018) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-018-0655-8 · Cited by 4
Mechanisms of Dopamine Oxidation and Parkinson’s Disease
Segura‐Aguilar, J., & Paris, I. B. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_16 · Cited by 3
Hamdon, S., Fernandez-Gonzalez, P., Omar, M. Y., González-Sepúlveda, M., Ortiz, J., & Gil, C. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109759 · Cited by 5
Dietary Iron Intake and Mental and Behavioral Disorders Due to Use of Tobacco: A UK Biobank Study
Qi, X., Zhang, R., Zhu, H., Luo, J., Zhang, Q., Wang, W., Wang, T., & Zhang, D. (2024) · Nutrients · doi:10.3390/nu17010039 · Cited by 3
A Personalized 14-3-3 Disease-Targeting Workflow Yields Repositioning Drug Candidates
Larasati, Y. A., Solis, G. P., Koval, A., Korff, C. M., & Katanaev, V. L. (2025) · Cells · doi:10.3390/cells14080559 · Cited by 4
“Of those, TH is regulated by phosphorylation in multiple sites (i.e., Thr8, Ser19, Ser 31, and Ser40) that alter its enzymatic kinetics [33,46].”
Ong, L. K., Page, S. L., Briggs, G. D., Guan, L., Dun, M. D., Verrills, N. M., Dunkley, P. R., & Dickson, P. W. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25839 · Cited by 5
“Interestingly, TH activity can be modulated by cytokines, and these cytokines exert a variety of effects on activation of TH, either by short-term non-genomic actions via influx of the extracellular calcium into the cells and activation of protein kinases that increase TH phosphorylation or long-term genomic actions v…”
BackgroundERK1/2 inhibition increases dopamine release from differentiated PC12 cells
Zosen, D., Dorofeeva, N. A., Chernigovskaya, E. V., Bachteeva, V. T., & Glazova, M. V. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.056 · Cited by 3
Kogure, M., Kanahara, N., Miyazawa, A., Shiko, Y., Otsuka, I., Matsuyama, K., Takase, M., Kimura, M., Kimura, H., Ota, K., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1334335 · Cited by 3
Douma, E. H., Stoop, J., Lingl, M. V. R., Smidt, M. P., & van der Heide, L. P. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01312-7 · Cited by 4
“This could be explained by the role of cAMP in positively regulating tyrosine hydroxylase mRNA expression and promoter activity [133–138], a pattern also observed in vivo in a Parkinson’s disease mouse model [139].”
BackgroundCluster Headache and Hypoxia: Breathing New Life into an Old Theory, with Novel Implications
Borkum, J. M. (2024) · Neurology International · doi:10.3390/neurolint16060123 · Cited by 2
Moghaddam, F. A., Binwal, M., Green, A. J., Rambacher, K. M., Wood, B. J., Murnane, K. S., & Moniri, N. H. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117685 · Cited by 2
OĞUZOĞLU, A. S., Asci, H., Aşcı, S., Canan, M., Taner, R., Gülal, A., Yalçın, İ. G., Öktem, M., Şenol, N., & Ozmen, O. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12006-3 · Cited by 2
Broggini, C., Abril, N., Membrillo, A., de la Peña, E., & Carranza, J. (2025) · BMC Genomics · doi:10.1186/s12864-025-11326-1 · Cited by 2
Biochemical and behavioural profile of NTBC treated Tyrosinemie type 1 mice
van Ginkel, W. G., Winn, S. R., Dudley, S., Krenik, D., Perez, R., Rimann, N., Thöny, B., Raber, J., & Harding, C. O. (2022) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2022.07.001 · Cited by 2
Mechanisms of Dopamine Oxidation and Parkinson’s Disease
Segura‐Aguilar, J., & Paris, I. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-71519-9_16-1 · Cited by 5
Tyrosine hydroxylase in the brain and its regulation by glucocorticoids
Sukhareva, E. V., Kalinina, T. S., Bulygina, V. V., & Дыгало, Н. Н. (2017) · Russian Journal of Genetics Applied Research · doi:10.1134/s2079059717030145 · Cited by 3
“The catalytic domains are involved in the formation of the tetramer through a leucine zipper (Tekin et al., 2014).”
Influential
Metadata
- Authors
- Tekin, I., Roskoski, R., Carkaci-Salli, N., & Vrana, K. E.
- Affiliations
- Pennsylvania State University (US)
- Corresponding author
- Vrana, Kent E.
- Venue
- Journal of Neural Transmission
- Published
- 2014-05-28
- Volume
- 121
- Issue
- 12
- Pages
- 1451-1481
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2055665256
- Cited by
- 128
- References
- 294
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 12 · 2023: 16 · 2022: 12 · 2021: 10 · 2020: 9 · 2019: 13 · 2018: 19 · 2017: 11 · 2016: 10 · 2015: 5
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM-38931, R01GM038931)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- tyrosine hydroxylase, catecholamine synthesis, enzyme regulation, epigenetic regulation, transcription factors, mRNA levels, product inhibition, protein phosphorylation, protein kinases, protein phosphatase, ubiquitin-proteasome degradation, protein-protein interaction
- MeSH terms
- Animals, Catecholamines, Humans, Models, Molecular, RNA, Messenger, Tyrosine 3-Monooxygenase, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.